The Fraunhofer IZI-BB

The Branch of Bioanalytics and Bioprocesses of IZI-BB focuses on analytics, diagnostics, biosystems technology and biological safety to address promising, sustainable fields of development.

The origins of the present-day Fraunhofer IZI-BB date back to 1998 with the founding of the Molecular Bioanalytics branch of Fraunhofer IBMT in Potsdam-Rehbrücke and its receipt of the BMBF BioFuture prize. In 2001, it was integrated into what was the Fraunhofer Working Group on Medical Biotechnology (ABMT) at the time. The branch of the IBMT, which has a total usable space of approximately 4,300 m2, was established in Potsdam-Golm in the budding research park near the University of Potsdam, the MPI and the Golm founder center. Construction began in 2004 and the inauguration took place in 2007.

As a result of implementing internal synergy-promoting strategies, the institute branch became affiliated with Fraunhofer IZI in 2014. The branch is the fourth Fraunhofer IZI center in Germany along with the main site in Leipzig, the Branch of Drug Design and Target Validation (IZI-MWT) in Halle (Saale) as well as the Branch of Extracorporeal Immunomodulation in Rostock. Due to its infrastructure and history, the administration of the institute branch is fully independent.

Privacy warning

With the click on the play button an external video from is loaded and started. Your data is possible transferred and stored to third party. Do not start the video if you disagree. Find more about the youtube privacy statement under the following link:

At Fraunhofer IZI-BB we develop rapid test systems for bioanalytics & diagnostics

Our research focuses on sample preparation, development of molecular recognition elements and data acquisition as well as miniaturization and automation of corresponding technologies in order to provide reliable, flexible and easy-to-use process flows for our customers. From lateral flow tests to immunoassays, we offer assay development and adaption throughout the entire process according to your requirements.

Organization Chart of the Fraunhofer IZI-BB

Director  Prof. Dr. Antje Baeumner
Deputy Director Dr. Eva Ehrentreich-Förster
Head of Administration Katja Okulla
Transfer and Exploitation Dr. Katharina Kasack
Biosystem Integration and Process Automation  
Head of Department PD Dr. Ralph Hölzel
ivD Platform/PoC Technologies Dr. Harald Peter
Biomolecular Nanostructures and Measurement Technology PD Dr. Ralph Hölzel
Biomimetic Functional Materials Dr. Nenad Gajovic-Eichelmann
Laboratory and Process Automation Dipl.-Biol. Jörg Henkel
Cell-free and Cell-based Bioproduction  
Head of Department Dr. Marcus Menger (acting)
Cell-free Protein Synthesis Dr. Anne Zemella (acting)
Eukaryotic Lysates Dipl.-Ing. Doreen Wüstenhagen
Functional Nucleic Acids – Aptamers Dr. Marcus Menger
Molecular and Cellular Bioanalytics  
Head of Department Dr. Eva Ehrentreich-Förster
Microarray and Sensor Technology Dr. Cornelia Hettrich (acting)
Biomarker Validation and Assay Development PD Dr. Harald Seitz
Molecular Bio Engineering Dr. Markus von Nickisch-Rosenegk
Microsystems for in vitro Cell Models Dr. Katja Uhlig
Microfluidic Cell Processing and Cell Analytics Dr. Michael Kirschbaum
Free working group  
Extremophile Research and Biobank CCCryo Dr. Thomas Leya
Project Group »PZ-Syn«  Location: Senftenberg  
Coordinator Dr. Jan Kiebist